Happenings

Edward J. Poziomek, former director of research, U.S. Army Chemical Research at the Development and Engineering Center at Aberdeen Proving Ground, Md., became Sigma Xi’s new executive director on December 1. Poziomek joined the society in 1961 and has served on the board of directors since 1976. His areas of research include surface chemistry, spectroscopy, physical-organic chemistry and organic synthesis. Charles E. Hammer Jr., associate vice president for health affairs and professor

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Edward J. Poziomek, former director of research, U.S. Army Chemical Research at the Development and Engineering Center at Aberdeen Proving Ground, Md., became Sigma Xi’s new executive director on December 1. Poziomek joined the society in 1961 and has served on the board of directors since 1976. His areas of research include surface chemistry, spectroscopy, physical-organic chemistry and organic synthesis.

Charles E. Hammer Jr., associate vice president for health affairs and professor of obstetrics and gynecology at the University of Virginia Medical Center, will become president of the North Carolina Biotechnology Center on February 1, 1988. Hammer will replace Richard J. Patterson, who resigned in December 1986. Roy E. Morse, retired vice president for research and development at R.J. Reynolds Industries, Inc., is interim president. The Biotechnology Center is a non-profit corporation funded by the N.C. General Assembly.

The Boyce Thompson Institute for Plant Research named Richard C. Staples the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies